Andreas Jung Selected Research

Andreas Jung Research Topics

Disease

64	Neoplasms (Cancer) 07/2022 - 04/2003
63	Colorectal Neoplasms (Colorectal Cancer) 07/2022 - 06/2002
18	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2004
14	Colonic Neoplasms (Colon Cancer) 01/2019 - 03/2007
8	Microsatellite Instability 07/2022 - 06/2002
8	Infections 01/2022 - 08/2002
8	Carcinogenesis 10/2013 - 10/2004
6	Inflammation (Inflammations) 06/2022 - 05/2003
6	Carcinoma (Carcinomatosis) 08/2012 - 02/2004
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2021 - 01/2011
5	Cystic Fibrosis (Mucoviscidosis) 10/2021 - 03/2013
4	Disease Progression 01/2022 - 05/2009
4	Lung Neoplasms (Lung Cancer) 11/2021 - 03/2011
4	Adenocarcinoma 11/2018 - 09/2006
4	Pancreatic Neoplasms (Pancreatic Cancer) 08/2014 - 08/2012
4	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 08/2010 - 07/2002
3	Asthma (Bronchial Asthma) 12/2017 - 07/2011
3	Metaplasia 11/2014 - 08/2004
3	Adenoma (Adenomas) 09/2012 - 02/2004
2	COVID-19 11/2022 - 01/2022
2	Hypersensitivity (Allergy) 11/2022 - 03/2013
2	Pseudomonas Infections 10/2021 - 03/2013
2	Chronic Obstructive Pulmonary Disease (COPD) 02/2016 - 01/2016
2	Weight Loss (Weight Reduction) 04/2011 - 12/2010
2	Virus Diseases (Viral Diseases) 11/2006 - 05/2006
2	Chylothorax 05/2006 - 11/2005
2	Stroke (Strokes) 05/2005 - 05/2003
1	Immediate Hypersensitivity 11/2022
1	Ciliary Motility Disorders (Primary Ciliary Dyskinesia) 01/2022
1	Lung Diseases (Lung Disease) 10/2021
1	Endometrial Neoplasms (Endometrial Cancer) 11/2018

Drug/Important Bio-Agent (IBA)

16	beta CateninIBA 08/2010 - 06/2002
15	Biomarkers (Surrogate Marker)IBA 10/2021 - 01/2009
14	Cetuximab (Erbitux)FDA Link 01/2022 - 03/2011
12	Bevacizumab (Avastin)FDA Link 01/2022 - 09/2014
12	ErbB Receptors (EGF Receptor)IBA 01/2021 - 03/2009
11	DNA (Deoxyribonucleic Acid)IBA 06/2022 - 06/2002
9	Irinotecan (Camptosar)FDA LinkGeneric 11/2021 - 03/2011
9	Proteins (Proteins, Gene)FDA Link 01/2019 - 01/2004
9	CateninsIBA 09/2015 - 11/2010
7	AntibodiesIBA 01/2021 - 05/2003
5	Messenger RNA (mRNA)IBA 11/2022 - 08/2010
5	Formaldehyde (Formol)FDA Link 12/2021 - 05/2012
5	RNA (Ribonucleic Acid)IBA 01/2021 - 05/2006
5	Codon (Codons)IBA 01/2017 - 01/2009
4	LigandsIBA 12/2020 - 08/2008
4	ParaffinIBA 01/2020 - 05/2012
4	Monoclonal AntibodiesIBA 04/2016 - 08/2002
4	Antiviral Agents (Antivirals)IBA 02/2016 - 05/2006
4	Oncogene Proteins (Oncogene Protein)IBA 01/2007 - 07/2002
3	Oxygen (Dioxygen)IBA 01/2022 - 08/2012
3	Fluorouracil (Carac)FDA LinkGeneric 11/2021 - 09/2014
3	Leucovorin (Folinic Acid)FDA Link 11/2021 - 09/2014
3	Cell-Free Nucleic AcidsIBA 01/2020 - 03/2011
3	Transcription Factors (Transcription Factor)IBA 01/2018 - 12/2005
3	Immunoglobulin E (IgE)IBA 12/2017 - 07/2011
3	Gemcitabine FDA Link 01/2017 - 08/2012
3	Erlotinib Hydrochloride (CP 358,774)FDA Link 08/2014 - 04/2013
3	Capecitabine (Xeloda)FDA Link 05/2013 - 03/2011
3	Calcibiotic Root Canal SealerIBA 09/2012 - 09/2006
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2012 - 08/2008
3	Cyclin-Dependent Kinase Inhibitor p16IBA 07/2011 - 01/2009
3	Biological ProductsIBA 12/2009 - 09/2006
2	NucleotidesIBA 07/2022 - 01/2020
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2022 - 12/2017
2	Circulating Tumor DNAIBA 01/2022 - 10/2017
2	Azithromycin (Zithromax)FDA LinkGeneric 10/2021 - 02/2015
2	Phosphotransferases (Kinase)IBA 01/2020 - 01/2020
2	tyrosine receptor (receptor, tyrosine)IBA 01/2020 - 01/2020
2	Indicators and Reagents (Reagents)IBA 01/2018 - 07/2011
2	Therapeutic UsesIBA 01/2018 - 01/2012
2	Differentiation AntigensIBA 11/2017 - 04/2014
2	Insulin (Novolin)FDA Link 01/2017 - 12/2010
2	ChemokinesIBA 03/2013 - 09/2012
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2013 - 03/2011
2	VimentinIBA 11/2012 - 06/2011
2	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 01/2012 - 11/2010
2	LipidsIBA 04/2011 - 12/2010
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2008 - 05/2006
2	Octreotide (Sandostatin)FDA LinkGeneric 05/2006 - 11/2005
2	Plasminogen Activators (Plasminogen Activator)IBA 05/2005 - 02/2004
1	COVID-19 VaccinesIBA 11/2022
1	VaccinesIBA 11/2022
1	mRNA VaccinesIBA 11/2022
1	Aurora Kinase AIBA 01/2022
1	Crk-Associated Substrate ProteinIBA 11/2021
1	Immune Checkpoint InhibitorsIBA 10/2021
1	B7-H1 AntigenIBA 10/2021
1	AmphiregulinIBA 12/2020
1	MagnesiumIBA 01/2020
1	Hormones (Hormone)IBA 12/2019
1	Cellular Retinol-Binding ProteinsIBA 01/2019

Therapy/Procedure

30	Therapeutics 01/2022 - 03/2009
5	Drug Therapy (Chemotherapy) 01/2019 - 04/2003
2	Critical Care (Surgical Intensive Care) 11/2020 - 07/2009
2	Combination Drug Therapy (Combination Chemotherapy) 01/2020 - 01/2019
2	Precision Medicine 01/2020 - 04/2016
1	Investigational Therapies (Experimental Therapy) 07/2022
1	Chemoradiotherapy 10/2021
1	Lung Transplantation 10/2021